10 Problems in Cardiovascular Care
and How We're Solving Them

Conventional cardiovascular screening frequently misses people with significant heart disease, creating false reassurance.

Normal cholesterol, blood pressure, body weight, or even a normal stress test or calcium score do not guarantee a low risk of heart disease. Because heart disease develops silently over decades, many people have advanced plaque long before symptoms or traditional tests become abnormal.

In fact:

• More than 50% of people who have a heart attack had no prior symptoms
• 50% have normal cholesterol
• 25% have a coronary calcium score of zero
• 70% pass a stress test shortly before their heart attack
• Landmark studies (Framingham, ARIC, and MESA) show that 60–80% of heart attacks occur in people not classified as high risk

Conventional cardiovascular care relies heavily on oversimplified risk calculators that estimate risk using a small number of variables, including age, sex, total and HDL cholesterol, blood pressure and diabetes status, and smoking.

While useful to an extent, these calculators were designed primarily to guide medication decisions, not to explain why someone is at risk. As a result, they often miss important biological drivers of heart disease and falsely reassure people with significant underlying disease.

It's common for two people with the same calculated risk score to have dramatically different actual cardiovascular risk.

Coronary artery calcium (CAC) scoring is the most commonly ordered cardiovascular imaging test — if imaging is ordered at all. While CAC detects calcified plaque, it cannot identify the earliest and often most dangerous forms of coronary artery disease, including:

• Non-calcified plaque
• Lipid-rich plaque
• High-risk (vulnerable) plaque
• Early atherosclerosis before calcification develops

A calcium score of zero does not guarantee healthy arteries. Approximately 20–25% of acute coronary events occur in people with a CAC score of zero, largely because many heart attacks result from rupture of non-calcified, vulnerable plaque, not stable calcified plaque.

Most laboratory results are interpreted using population-based reference ranges, which reflect what is statistically common, not what is optimal for health.

As a result, many people are told their labs are "normal" while early metabolic dysfunction, inflammation, nutrient deficiencies, and cardiovascular risk are already developing.

Insulin resistance is a prime example. It often exists for years before blood sugar or HbA1c rises enough to meet the criteria for prediabetes or diabetes, allowing vascular damage and metabolic dysfunction to progress unaddressed.

Many people seeking a more complete understanding of their cardiovascular health cannot access advanced testing, including:

• Advanced lipid, metabolic, inflammatory and full body system biomarkers
• Coronary CT angiography (CCTA)

This happens for two main reasons:

• Many clinicians do not routinely order these tests because they fall outside traditional screening guidelines.
• Insurance companies often deny coverage when testing does not meet their medical necessity criteria.

If all you have is a hammer, everything looks like a nail.

Conventional cardiovascular care often focuses heavily on medications and lab values while overlooking the underlying biology driving disease.

Common limitations include:

• Treating numbers instead of biology and root causes
• False reassurance from improved cholesterol values
• Limited attention to metabolic health, inflammation, lifestyle, and environmental factors

While medications like statins can be important and lifesaving for many people, they do not directly address many of the causes of elevated cholesterol and coronary artery disease:

• Insulin resistance
• Chronic inflammation
• Thyroid disease
• Vitamin and nutrient deficiency
• Poor nutrition
• Sedentary lifestyle
• Poor sleep
• Environmental exposures

Cholesterol is one of the most misunderstood topics in cardiovascular healthcare. Many people, including well-intentioned clinicians, view and treat it too simplistically.

The reality is more nuanced:

• High cholesterol is not always harmful.
• Low cholesterol is not always protective.
• Lowering cholesterol numbers does not automatically translate into reduced risk

The same cholesterol number can mean very different things in different people. Some individuals with low cholesterol have significant coronary plaque, while others with high cholesterol have little or no plaque burden.

It would be easier if high = bad and low = good, but cardiovascular biology is far more complex. A complete assessment of what's driving cholesterol levels and cardiac disease requires looking beyond a standard lipid panel and considering:

• LDL particle number, size, and density
• Lipoprotein quality and composition
• Inflammation and oxidative stress
• Metabolic health and insulin resistance
• Thyroid dysfunction and hormones
• Vitamin and nutrient deficiencies
• GI, liver and gallbladder function
• Sleep, stress, alcohol, and drug use
• Exercise patterns, including overtraining
• Overall clinical context

Most medical visits last only 10–30 minutes and happen only once or twice per year. No clinician can fully evaluate dozens of cardiovascular risk factors, connect the dots, and create a personalized plan in that limited time.

Even when working with multiple providers — a PCP, cardiologist, nutritionist, or therapist — care often remains fragmented, with no one person synthesizing the complete picture of your health.

Patients are often left to:

• Research answers on their own between visits
• Advocate for additional testing
• Coordinate fragmented care
• Make decisions without enough time to understand all their options

Doctors can only counsel patients based on what their training taught them and with the limited time available during an office visit. As a result, important conversations about the evidence, benefits, risks, limitations, and uncertainties behind medical recommendations often never happen.

Many patients feel:

• Medication side effects are minimized or dismissed
• Questions are discouraged rather than explored
• Treatment limitations and alternatives are not fully discussed
• They are uncomfortable asking questions or challenging recommendations

This is especially true for complex and sometimes controversial topics such as cholesterol management and statin therapy, where patients often want to better understand:

• Who is most likely to benefit
• The magnitude and limitations of benefit
• Potential risks, side effects, and trade-offs

Medicine is constantly evolving. Evidence changes, and uncertainty is a normal part of science. Yet many patients feel healthcare leaves little room for curiosity, discussion, or critical evaluation of the evidence.

Many patients tell us they feel like they are frustrating or even angering their doctor if they ask questions or decline or defer starting the recommended medications. Too often, the relationship feels less like a partnership and more like comply or goodbye.